Trusted Resource for Clinical Trials, Protocols & Progress
CTMS ↔ eTMF Data Mapping Guide: Fields, Ownership, Audit Trails CTMS ↔ eTMF Data Mapping: Field-Level Rules, Ownership, and Audit Trails That Stand Up in FDA/MHRA Inspections Why precise CTMS–eTMF mapping wins inspections: from “two versions of truth” to one stitched record Define the outcome: one story told by two systems The purpose of a…
Read More “CTMS ↔ eTMF Data Mapping Guide: Fields, Ownership, Audit Trails” »
NHS/NIHR Site Enablement: Capacity, Governance, Templates NHS/NIHR Site Enablement: Building Capacity, Proving Governance, and Using Templates That Survive Inspection Why NHS/NIHR enablement decides UK enrollment velocity—and how to make it inspection-ready for US/UK/EU reviewers The enablement problem in one sentence Most UK programs stall not at feasibility, but between local confirmations and the first clinic…
Read More “NHS/NIHR Site Enablement: Capacity, Governance, Templates” »
Cut Delays: Prior Authorization, Imaging, Scheduling Bottlenecks Cut Delays Fast: How to Tame Prior Authorization, Imaging Queues, and Scheduling Bottlenecks Without Losing Compliance Why cycle-time kills enrollment—and the exact levers that buy back weeks in US/UK/EU programs The three hidden clocks that decide whether you randomize on time Across high-enrolling studies, cycle-time failures track back…
Read More “Cut Delays: Prior Authorization, Imaging, Scheduling Bottlenecks” »
Feasibility Questions That Predict Enrollment (Scoring Sheet) Feasibility Questions That Actually Predict Enrollment: A Defensible Scoring Sheet for US/UK/EU Programs Why feasibility must predict enrollment—not just describe the site—and how to make it inspection-ready From “profile of a site” to “probability of randomization” Traditional questionnaires catalog capabilities—beds, scanners, prior trials—but rarely answer the business-critical question:…
Read More “Feasibility Questions That Predict Enrollment (Scoring Sheet)” »
